RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
-1.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.75B
AUM Growth
-$879M
(-33%)
Cap. Flow
-$729M
Cap. Flow
% of AUM
-41.7%
Top 10 Holdings %
Top 10 Hldgs %
36.57%
Holding
113
New
6
Increased
25
Reduced
47
Closed
16
Top Buys
| 1 |
Tarsus Pharmaceuticals
TARS
|
$12.5M |
| 2 |
Danaher
DHR
|
$12.1M |
| 3 |
Evolent Health
EVH
|
$6.02M |
| 4 |
Mineralys Therapeutics
MLYS
|
$5.09M |
| 5 |
Merus
MRUS
|
$3.71M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$56.5M |
| 2 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 3 |
Freshpet
FRPT
|
$48.5M |
| 4 |
UnitedHealth
UNH
|
$39.5M |
| 5 |
Travere Therapeutics
TVTX
|
$36.8M |
Sector Composition
| 1 | Healthcare | 99.7% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Crinetics Pharmaceuticals
CRNX
$3.35B
| – | – |
-294,100
| Closed | -$15M |
|
|
102
Freshpet
FRPT
$2.7B
| – | – |
-327,500
| Closed | -$48.5M |
|
103
Lifestance Health
LFST
$2.09B
| – | – |
-2,550,000
| Closed | -$18.8M |
|
104
Leap Therapeutics
LPTX
$11.7M
| – | – |
-1,266,546
| Closed | -$3.64M |
|
105
Neumora Therapeutics
NMRA
$272M
| – | – |
-955,106
| Closed | -$10.1M |
|
106
Insulet
PODD
$24.5B
| – | – |
-114,250
| Closed | -$29.8M |
|
|
SWTX
107
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-328,911
| Closed | -$11.9M |
|
108
Xilio Therapeutics
XLO
$36.3M
| – | – |
-3,003,259
| Closed | -$2.87M |
|
109
Xencor
XNCR
$610M
| – | – |
-401,013
| Closed | -$9.22M |
|
110
Kyverna Therapeutics
KYTX
$170M
| – | – |
-178,963
| Closed | -$669K |
|
|
VINC
111
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| – | – |
-44,586
| Closed | -$234K |
|